TY - JOUR
KW - collaborative care
KW - community pharmacy
KW - Implementation-efficiency trial
KW - MOUD
KW - opioid agonist treatment
KW - study protocol
AU - S. Nielsen
AU - A. Cheetham
AU - J. Jackson
AU - S. Lord
AU - D. Petrie
AU - D. Jacka
AU - L. Picco
AU - K. Morgan
A1 - 
AD - Monash Addiction Research Centre, Eastern Health Clinical School, Monash University Peninsula Campus, Frankston, Victoria, Australia. Electronic address: suzanne.nielsen@monash.edu.; Monash Addiction Research Centre, Eastern Health Clinical School, Monash University Peninsula Campus, Frankston, Victoria, Australia.; Centre for Medicine Use and Safety (CMUS), Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.; Pharmacotherapy Mediation, Advocacy, and Support (PAMS), Harm Reduction Victoria, Australia.; Centre for Health Economics, Monash Business School, Caulfield East, Victoria, Australia.; Monash Health Drug and Alcohol Service, Monash Health, Melbourne, Victoria, Australia.; Monash Addiction Research Centre, Eastern Health Clinical School, Monash University Peninsula Campus, Frankston, Victoria, Australia.; Frankston Mornington Peninsula Primary Care Partnership, Peninsula Health, Australia.
BT - Research in social & administrative pharmacy : RSAP
C5 - Education & Workforce; Opioids & Substance Use
CY - United States
DO - 10.1016/j.sapharm.2021.11.007
JF - Research in social & administrative pharmacy : RSAP
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2021
SN - 1934-8150; 1551-7411
T1 - A prospective, multisite implementation-efficacy trial of a collaborative prescriber-pharmacist model of care for Medication Assisted Treatment for Opioid Dependence: Protocol for the EPIC-MATOD study
T2 - Research in social & administrative pharmacy : RSAP
TI - A prospective, multisite implementation-efficacy trial of a collaborative prescriber-pharmacist model of care for Medication Assisted Treatment for Opioid Dependence: Protocol for the EPIC-MATOD study
U1 - Education & Workforce; Opioids & Substance Use
U2 - 34924314
U3 - 10.1016/j.sapharm.2021.11.007
VO - 1934-8150; 1551-7411
Y1 - 2021
Y2 - Nov 18
ER -